Correlates of improved outcomes in patients with COVID-19 treated in US emergency departments
Operational and clinical outcomes of ED-based treatment of individuals with COVID-19 improved in the first two years of the pandemic. This improvement is likely multifactorial and includes the development and deployment of SARS-CoV-2-specific vaccines, therapeutic agents, and improved healthcare delivery in the ED and elsewhere addressing management of airway and ventilatory status, as well as increased innate immunity in the general population.
Authors
- Michael C. Fiore (ORCID: https://orcid.org/0000-0003-3460-1691)
- Karen L. Conner (ORCID: https://orcid.org/0000-0002-6116-168X)
- Thomas M. Piasecki (ORCID: https://orcid.org/0000-0002-2793-2049)
- Steven L. Bernstein (ORCID: https://orcid.org/0000-0002-9964-7036)
- Wendy S. Slutske
- Brian Williams (ORCID: https://orcid.org/0000-0003-0000-4354)
- J.M. Kirsch
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- University of Wisconsin–Madison (US)
Publication Details
- Journal
- The American Journal of Emergency Medicine
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1016/j.ajem.2024.09.035
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28